Vera Therapeutics Company Insiders

Vera Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.3337) % which means that it has lost $0.3337 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6511) %, meaning that it created substantial loss on money invested by shareholders. Vera Therapeutics' management efficiency ratios could be used to measure how well Vera Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of November 29, 2024, Return On Tangible Assets is expected to decline to -0.57. In addition to that, Return On Capital Employed is expected to decline to -0.7. The current year's Net Tangible Assets is expected to grow to about 92.9 M, whereas Total Assets are forecasted to decline to about 99.1 M. The current year's Net Income Applicable To Common Shares is expected to grow to about 107.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 21.5 M.

Vera Therapeutics Workforce Comparison

Vera Therapeutics Insider Trading History

Vera Therapeutics Notable Stakeholders

The success or failure of an entity such as Vera Therapeutics often depends on how effective the management is. Vera Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Vera Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vera Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vera Therapeutics' management manipulating its earnings.

When running Vera Therapeutics' price analysis, check to measure Vera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vera Therapeutics is operating at the current time. Most of Vera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vera Therapeutics' price. Additionally, you may evaluate how the addition of Vera Therapeutics to your portfolios can decrease your overall portfolio volatility.